Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
6.86
+0.30 (4.57%)
Apr 24, 2025, 10:58 AM EDT - Market open

Quoin Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Cash & Equivalents
3.622.42.867.480.32
Upgrade
Short-Term Investments
10.438.299.99--
Upgrade
Cash & Short-Term Investments
14.0610.6912.857.480.32
Upgrade
Cash Growth
31.44%-16.79%71.78%2210.70%-
Upgrade
Prepaid Expenses
0.870.590.520.72-
Upgrade
Other Current Assets
----0.14
Upgrade
Total Current Assets
14.9311.2913.378.20.47
Upgrade
Other Intangible Assets
0.480.580.70.810.91
Upgrade
Other Long-Term Assets
0.30.30.380.35-
Upgrade
Total Assets
15.7112.1714.469.361.38
Upgrade
Accounts Payable
0.910.530.610.92-
Upgrade
Accrued Expenses
2.682.452.322.434.99
Upgrade
Short-Term Debt
----1.21
Upgrade
Current Portion of Long-Term Debt
0.60.60.60.6-
Upgrade
Other Current Liabilities
---0.621.78
Upgrade
Total Current Liabilities
4.183.583.534.587.99
Upgrade
Long-Term Debt
2.322.923.524.12-
Upgrade
Total Liabilities
6.56.517.058.77.99
Upgrade
Additional Paid-In Capital
64.3751.8747.8631.660
Upgrade
Retained Earnings
-55.17-46.2-37.52-28.07-6.61
Upgrade
Treasury Stock
---2.93-2.93-
Upgrade
Shareholders' Equity
9.25.667.410.66-6.61
Upgrade
Total Liabilities & Equity
15.7112.1714.469.361.38
Upgrade
Total Debt
2.923.524.124.721.21
Upgrade
Net Cash (Debt)
11.137.178.732.76-0.89
Upgrade
Net Cash Growth
55.25%-17.85%216.41%--
Upgrade
Net Cash Per Share
83.11278.59---
Upgrade
Filing Date Shares Outstanding
0.590.110.03-0.03
Upgrade
Total Common Shares Outstanding
0.260.030.01-0.03
Upgrade
Working Capital
10.757.79.843.62-7.52
Upgrade
Book Value Per Share
36.00200.81641.72--231.26
Upgrade
Tangible Book Value
8.725.086.7-0.15-7.52
Upgrade
Tangible Book Value Per Share
34.11180.13580.68--263.20
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q